Showing results (11-20 of 103) with videos related to

Sort By:
Pageof 11
International Immunology|February 23, 2012
Expression pattern changes and function of RANKL during mouse lymph node microarchitecture developmentMachiko Sugiyama, Gaku Nakato, Toshi Jinnohara, et al.
Plos One|April 22, 2015
Effect of TIM-3 Blockade on the Immunophenotype and Cytokine Profile of Murine Uterine NK CellsSudipta Tripathi, Lola Chabtini, Pranal J Dakle, et al.
American Journal of Physiology. Renal Physiology|March 14, 2014
Endogenous Tim-1 promotes severe systemic autoimmunity and renal disease MRL-Fas(lpr) miceYuji Nozaki, A Richard Kitching, Hisaya Akiba, et al.
Cancer Immunology, Immunotherapy : CII|November 13, 2012
Combined blockade of TIM-3 and TIM-4 augments cancer vaccine efficacy against established melanomasMuhammad Baghdadi, Hiroko Nagao, Hironori Yoshiyama, et al.
Biochemical and Biophysical Research Communications|July 4, 2006
Amelioration of bone loss in collagen-induced arthritis by neutralizing anti-RANKL monoclonal antibodySeiji Kamijo, Atsuo Nakajima, Kaori Ikeda, et al.
The Journal of Allergy and Clinical Immunology|January 10, 2009
Notch signaling confers antigen-presenting cell functions on mast cellsNobuhiro Nakano, Chiharu Nishiyama, Hideo Yagita, et al.
Blood|February 20, 2009
Tim-3 mediates phagocytosis of apoptotic cells and cross-presentationMasafumi Nakayama, Hisaya Akiba, Kazuyoshi Takeda, et al.
Advanced Therapeutics|April 23, 2021
ImmunoPET Imaging of TIM-3 in Murine Melanoma ModelsWeijun Wei, Dawei Jiang, Hye Jin Lee, et al.
Biochemical and Biophysical Research Communications|January 28, 2014
OX40 ligand regulates splenic CD8⁻ dendritic cell-induced Th2 responses in vivoFumitaka Kamachi, Norihiro Harada, Yoshihiko Usui, et al.
Pageof 11